Table 2.
Adherence with local guidelines
| Diagnosis confirmed clinically and biochemically | 100% |
| Removal of potential culprit drugs | 100% |
| Exclusion of adrenal / thyroid pathology | 100% |
| Documentation of fluid balance status and charts | 92% |
| Documentation of 48 h fluid restriction prior to starting Tolvaptan | 96% |
| Tolvaptan initiation according to Trust policy | 96% |
| Na level monitoring before/after initiation as per recommendations | 96% |